Selected article for: "safety efficacy and vaccine development"

Author: Chen, Wei; Zhu, Feng-Cai
Title: Challenges in the development of a vaccine against COVID-19
  • Cord-id: q8opsa8p
  • Document date: 2020_9_14
  • ID: q8opsa8p
    Snippet: SARS-CoV-2, the causal agent of COVID-19, has become a major public health issue. The severe morbidity and mortality associated with SARS-CoV-2 necessitate the development of effective vaccines to prevent epidemics. There is an unprecedented need to produce and distribute enough safe and effective vaccines to individuals globally. Here, we discuss the challenges in several aspects including the vaccine safety, vaccine efficacy, human challenge trials and production capacity in COVID-19 vaccine d
    Document: SARS-CoV-2, the causal agent of COVID-19, has become a major public health issue. The severe morbidity and mortality associated with SARS-CoV-2 necessitate the development of effective vaccines to prevent epidemics. There is an unprecedented need to produce and distribute enough safe and effective vaccines to individuals globally. Here, we discuss the challenges in several aspects including the vaccine safety, vaccine efficacy, human challenge trials and production capacity in COVID-19 vaccine development.

    Search related documents:
    Co phrase search for related documents
    • live vaccine and local mucosal immunity: 1, 2, 3, 4, 5